Less than a day remains until Oct. 17.
The sun's going to rise on a different world tomorrow, one in which medical and - importantly - recreational marijuana will be freely available for purchase and use by consenting Canadian adults from the Yukon to Newfoundland.
Investors have even more to look forward to.
The latest analyst estimates (they're consistently being revised upward) could hardly be more bullish.
Research firm Deloitte expects - once you consider the growers, the value-added product makers, the testing labs, security, tourism, exports, and all the rest - the Canadian legal cannabis market soon could reach an eye-watering $22.6 billion.
And even at this late hour, there are still some must-own stocks that American investors can buy - easily, I'd add - to leverage this historic moneymaking opportunity.
Make sure you grab shares of these today...
[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
- Canopy Growth Corp. (NASDAQ: CGC) has soared 1,528%.
- Aurora Cannabis Inc. (OTC: ACBFF) has rocketed 1,289%.
Out of fairness to my readers, I kept these picks close to the vest, but soon the gains were too much to keep a lid on, and I published some recommendations here in Money Morning.
Now, pot stocks - especially Canadian companies - have had an incredible summer, rocketing several hundred percent since mid-July.
As my colleagues have said, the gains are barely getting started. Investors who may have hung back while these stocks soared 300%... 400%... 500% haven't missed out on the main event.
I fully expect the upside for these cannabis firms to remain strong. Remember, many of these firms will be able to ring up recreational sales - and by all accounts plenty of them - by this time tomorrow.
This is the perfect time to buy.
How Canada's Market Will Pick Up Steam
Now, you may have heard about how the number of licensed cannabis stores opening on Oct. 17 is low in some Canadian provinces. That's true. British Columbia, with 4.8 million residents, has licensed a single store to date.
Ontario, Canada's most populous province, with 13.6 million residents, won't have a single store open. But that's because provincial leaders opted to allow for privately owned cannabis shops just this June, so regulators need more time to set up Ontario's system.
However, before you start to get worried, here's the bottom line: Each province, by law, must provide an online purchasing program that will be up and running on Oct. 17. That means everyone in Canada who wants to will be able to purchase their cannabis from that day forward.
Many of them will just have to go online to do so.
Not only that, but the provinces have vowed to license more stores - and soon. Manitoba wants a cannabis store within a 30-minute drive for 90% of its residents, for example.
Canadian cannabis sales could soar - drastically - in mere days. Try to think of another nationwide industry out there that's essentially going from "0 to 60 mph" in terms of sales in less than a week.
So make sure you own Canopy and Aurora, at minimum, by close of business today. And make sure you're signed up to get all of our pot stock research "Profit Alerts" (you can click the button to do that, absolutely free).
Then, buckle up.
Because if investors take this opportunity seriously, according to our calculations, they could make $2 million or more by this time next year.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.